[96a5a0]: / output / allTrials / identified / NCT05327465_identified.json

Download this file

499 lines (499 with data), 21.5 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
{
"info": {
"nct_id": "NCT05327465",
"official_title": "Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy: POWER Trial",
"inclusion_criteria": "* Patients must meet all criteria to be eligible, including travel to Dana-Farber Cancer Institute (DFCI) to collect research data to address the study question.\n* Over 18 years old; children under the age of 18 will be excluded due to the rarity of the disease\n* Histologically diagnosed of localized or metastatic prostate cancer\n* Have been receiving androgen deprivation therapy (ADT) (i.e., luteinizing hormone-releasing hormone [LHRH] agonist/antagonist and/or androgen receptor [AR] agonist/antagonist) for at least one month with a plan to continue ADT for at least 4 months at the time of recruitment\n* Self-identify as Black\n* Medically cleared to participate in exercise by their referred physician or a certified clinical exercise physiologist\n* Are without medical conditions that could exacerbate with exercise, such as bone disease (excluding bone metastases) at imminent risk of fracture or uncontrolled cardiopulmonary or metabolic diseases\n* Speak English and/or Spanish\n* Currently participate in less than or equal to 60 minutes of moderate or vigorous structured exercise/week\n* Willing to travel to DFCI for necessary data collection\n* Ability to communicate and complete written forms in English and/or Spanish\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Are not receiving ADT (i.e., LHRH agonist/antagonist and/or AR agonist/antagonist)\n* Pre-existing medical conditions such as uncontrolled cardiopulmonary disease, or metabolic diseases that could exacerbate with exercise\n* Are not English or Spanish speaking\n* Patients with secondary diagnosis (with the exception of basal cell carcinoma)\n* Participate in more than 60 minutes of moderate or vigorous structured exercise/week\n* Unable to travel to DFCI for necessary data collection\n* May not be able to comply with the safety monitoring requirements of the study in the opinion of the investigator.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients must meet all criteria to be eligible, including travel to Dana-Farber Cancer Institute (DFCI) to collect research data to address the study question.",
"criterions": [
{
"exact_snippets": "travel to Dana-Farber Cancer Institute (DFCI)",
"criterion": "ability to travel to DFCI",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Over 18 years old; children under the age of 18 will be excluded due to the rarity of the disease",
"criterions": [
{
"exact_snippets": "Over 18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "children under the age of 18 will be excluded",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum age",
"expected_value": {
"operator": "<",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Histologically diagnosed of localized or metastatic prostate cancer",
"criterions": [
{
"exact_snippets": "Histologically diagnosed",
"criterion": "histological diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "localized or metastatic prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"localized",
"metastatic"
]
}
]
}
]
},
{
"line": "* Have been receiving androgen deprivation therapy (ADT) (i.e., luteinizing hormone-releasing hormone [LHRH] agonist/antagonist and/or androgen receptor [AR] agonist/antagonist) for at least one month with a plan to continue ADT for at least 4 months at the time of recruitment",
"criterions": [
{
"exact_snippets": "Have been receiving androgen deprivation therapy (ADT)",
"criterion": "androgen deprivation therapy (ADT)",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "month"
}
}
]
},
{
"exact_snippets": "plan to continue ADT for at least 4 months",
"criterion": "androgen deprivation therapy (ADT)",
"requirements": [
{
"requirement_type": "planned duration",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Self-identify as Black",
"criterions": [
{
"exact_snippets": "Self-identify as Black",
"criterion": "race",
"requirements": [
{
"requirement_type": "self-identification",
"expected_value": "Black"
}
]
}
]
},
{
"line": "* Medically cleared to participate in exercise by their referred physician or a certified clinical exercise physiologist",
"criterions": [
{
"exact_snippets": "Medically cleared to participate in exercise by their referred physician or a certified clinical exercise physiologist",
"criterion": "medical clearance for exercise",
"requirements": [
{
"requirement_type": "authority",
"expected_value": [
"referred physician",
"certified clinical exercise physiologist"
]
}
]
}
]
},
{
"line": "* Are without medical conditions that could exacerbate with exercise, such as bone disease (excluding bone metastases) at imminent risk of fracture or uncontrolled cardiopulmonary or metabolic diseases",
"criterions": [
{
"exact_snippets": "medical conditions that could exacerbate with exercise",
"criterion": "medical conditions exacerbated by exercise",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "bone disease (excluding bone metastases) at imminent risk of fracture",
"criterion": "bone disease at imminent risk of fracture",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled cardiopulmonary ... diseases",
"criterion": "uncontrolled cardiopulmonary diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled ... metabolic diseases",
"criterion": "uncontrolled metabolic diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Speak English and/or Spanish",
"criterions": [
{
"exact_snippets": "Speak English and/or Spanish",
"criterion": "language",
"requirements": [
{
"requirement_type": "proficiency",
"expected_value": [
"English",
"Spanish"
]
}
]
}
]
},
{
"line": "* Currently participate in less than or equal to 60 minutes of moderate or vigorous structured exercise/week",
"criterions": [
{
"exact_snippets": "Currently participate in less than or equal to 60 minutes of moderate or vigorous structured exercise/week",
"criterion": "structured exercise participation",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<=",
"value": 60,
"unit": "minutes/week"
}
}
]
}
]
},
{
"line": "* Willing to travel to DFCI for necessary data collection",
"criterions": [
{
"exact_snippets": "Willing to travel to DFCI",
"criterion": "willingness to travel",
"requirements": [
{
"requirement_type": "location",
"expected_value": "DFCI"
}
]
}
]
},
{
"line": "* Ability to communicate and complete written forms in English and/or Spanish",
"criterions": [
{
"exact_snippets": "Ability to communicate ... in English and/or Spanish",
"criterion": "language communication ability",
"requirements": [
{
"requirement_type": "language",
"expected_value": [
"English",
"Spanish"
]
}
]
},
{
"exact_snippets": "complete written forms in English and/or Spanish",
"criterion": "written form completion ability",
"requirements": [
{
"requirement_type": "language",
"expected_value": [
"English",
"Spanish"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Are not receiving ADT (i.e., LHRH agonist/antagonist and/or AR agonist/antagonist)",
"criterions": [
{
"exact_snippets": "Are not receiving ADT",
"criterion": "ADT (androgen deprivation therapy)",
"requirements": [
{
"requirement_type": "receiving",
"expected_value": false
}
]
},
{
"exact_snippets": "LHRH agonist/antagonist",
"criterion": "LHRH agonist/antagonist",
"requirements": [
{
"requirement_type": "receiving",
"expected_value": false
}
]
},
{
"exact_snippets": "AR agonist/antagonist",
"criterion": "AR agonist/antagonist",
"requirements": [
{
"requirement_type": "receiving",
"expected_value": false
}
]
}
]
},
{
"line": "* Pre-existing medical conditions such as uncontrolled cardiopulmonary disease, or metabolic diseases that could exacerbate with exercise",
"criterions": [
{
"exact_snippets": "uncontrolled cardiopulmonary disease",
"criterion": "cardiopulmonary disease",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "metabolic diseases that could exacerbate with exercise",
"criterion": "metabolic diseases",
"requirements": [
{
"requirement_type": "exacerbation with exercise",
"expected_value": true
}
]
}
]
},
{
"line": "* Are not English or Spanish speaking",
"criterions": [
{
"exact_snippets": "Are not English or Spanish speaking",
"criterion": "language",
"requirements": [
{
"requirement_type": "language",
"expected_value": [
"English",
"Spanish"
]
}
]
}
]
},
{
"line": "* Patients with secondary diagnosis (with the exception of basal cell carcinoma)",
"criterions": [
{
"exact_snippets": "Patients with secondary diagnosis",
"criterion": "secondary diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "with the exception of basal cell carcinoma",
"criterion": "basal cell carcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Participate in more than 60 minutes of moderate or vigorous structured exercise/week",
"criterions": [
{
"exact_snippets": "Participate in more than 60 minutes of moderate or vigorous structured exercise/week",
"criterion": "exercise participation",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 60,
"unit": "minutes/week"
}
},
{
"requirement_type": "intensity",
"expected_value": [
"moderate",
"vigorous"
]
},
{
"requirement_type": "structure",
"expected_value": "structured"
}
]
}
]
},
{
"line": "* Unable to travel to DFCI for necessary data collection",
"criterions": [
{
"exact_snippets": "Unable to travel to DFCI",
"criterion": "ability to travel to DFCI",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* May not be able to comply with the safety monitoring requirements of the study in the opinion of the investigator.",
"criterions": [
{
"exact_snippets": "comply with the safety monitoring requirements of the study",
"criterion": "compliance with safety monitoring requirements",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}